Brief: Suven Pharmaceuticals' Unit Casper Pharma Receives EIR From USFDA For Pre-Approval Inspection
Oct 4 (Reuters) - Suven Pharmaceuticals Ltd SUVH.NS :
* CASPER PHARMA RECEIVED EIR FROM USFDA FOR PRE-APPROVAL
INSPECTION
Further company coverage: SUVH.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cohance Lifesciences
See all newsBrief: Cohance Lifesciences Names Abhimanyu Ojha As CFO
Brief: Cohance Lifesciences Says U.S. FDA Issues Form 483 With Five Observations For Jaggaiahpet Unit In Andhra Pradesh
India's Cohance Lifesciences falls after US FDA inspection at Telangana plant
Brief: Cohance Lifesciences Says Investment Of USD 18 Million In NJ Bio And Aruka Bio
India's Cohance Lifesciences climbs on second-half growth outlook despite Q1 loss